CAMPUS LECTURE | Madiha Derouazi (Alumni Award 2023)
Event details
| Date | 27.11.2023 |
| Hour | 12:15 › 14:00 |
| Location | |
| Category | Conferences - Seminars |
| Event Language | English |
"From Scientist to Entrepreneur: Bridging the Gap to Bring Vaccines to the Clinic"
Madiha Derouazi, CEO of Speransa Therapeutics, Founder and former CEO of Amal Therapeutics, Alumni Award 2023 and EPFL alumna
About the Campus Lecture
After obtaining her PhD from EPFL in 2005, Madiha Derouazi embarked on a venture that few people believed in: creating a vaccine to treat cancer. Yet she went on to develop her technology, and founded a business – AMAL Therapeutics – to market it.
During her lecture, she will share her experience and learnings on what it takes to move from a life as a scientist to become an entrepreneur and will presenting her research.
About Madiha Derouazi
Madiha Derouazi has been working on vector engineering and vaccine design for over 15 years. In 2012, she founded AMAL Therapeutics, a biotech company developing therapeutic cancer vaccines. The company was acquired by Boehringer Ingelheim in July 2019 for CHF425 million. She is now the CEO of Speransa Therapeutics, a clinical-stage Biotech with a Focus on COVID-19 Vaccine Development.
Madiha Derouazi holds a Master's degree from Berlin's Technische Universität, followed by a PhD in biotechnology from EPFL in 2005. She was awarded the European Inventor Prize in 2022. At this year's Magistrale, she received an "Alumni Award" from the School for the exceptional quality of her entrepreneurial career.
Programme
12:15pm Welcome address
Leïla Ojjeh, EPFL Alumni Director
12:20pm Introduction
Andrew Oates, Professor and SV School Dean, EPFL
12:25pm Campus Lecture
"From Scientist to Entrepreneur: Bridging the Gap to Bring Vaccines to the Clinic"
Madiha Derouazi (PhD CGC’05), CEO of Speransa Therapeutics, Founder and former CEO of Amal Therapeutics
01:10pm Q&A
01:25pm Networking aperitif
02:00pm End of the event
Madiha Derouazi, CEO of Speransa Therapeutics, Founder and former CEO of Amal Therapeutics, Alumni Award 2023 and EPFL alumna
About the Campus Lecture
After obtaining her PhD from EPFL in 2005, Madiha Derouazi embarked on a venture that few people believed in: creating a vaccine to treat cancer. Yet she went on to develop her technology, and founded a business – AMAL Therapeutics – to market it.
During her lecture, she will share her experience and learnings on what it takes to move from a life as a scientist to become an entrepreneur and will presenting her research.
About Madiha Derouazi
Madiha Derouazi has been working on vector engineering and vaccine design for over 15 years. In 2012, she founded AMAL Therapeutics, a biotech company developing therapeutic cancer vaccines. The company was acquired by Boehringer Ingelheim in July 2019 for CHF425 million. She is now the CEO of Speransa Therapeutics, a clinical-stage Biotech with a Focus on COVID-19 Vaccine Development.
Madiha Derouazi holds a Master's degree from Berlin's Technische Universität, followed by a PhD in biotechnology from EPFL in 2005. She was awarded the European Inventor Prize in 2022. At this year's Magistrale, she received an "Alumni Award" from the School for the exceptional quality of her entrepreneurial career.
Programme
12:15pm Welcome address
Leïla Ojjeh, EPFL Alumni Director
12:20pm Introduction
Andrew Oates, Professor and SV School Dean, EPFL
12:25pm Campus Lecture
"From Scientist to Entrepreneur: Bridging the Gap to Bring Vaccines to the Clinic"
Madiha Derouazi (PhD CGC’05), CEO of Speransa Therapeutics, Founder and former CEO of Amal Therapeutics
01:10pm Q&A
01:25pm Networking aperitif
02:00pm End of the event
Links
Practical information
- General public
- Registration required